Marc Montana (M Montana)

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 6

Top Topics

General Practice

Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Top Venues

Journal of clinical pharmacy and therapeutics

Targeted oncology

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Vincent Montero, Marc Montana, Omar Khoumeri, Florian Correard, Marie-Anne Estève, Patrice Vanelle
Synthesis, In Vitro Antiproliferative Activity, and In Silico Evaluation of Novel Oxiranyl-Quinoxaline Derivatives. Pharmaceuticals (Basel, Switzerland) 15 (7) (2022)
Sandrine Payan, Marc Montana, Christophe Curti, Laurent Greillier, Patrice Vanelle
Antibody-Drug Conjugates in Thoracic Malignancies: Clinical Trials Reveal Both Promise and Challenges. Targeted oncology 15 (4) (2021)
François Cavaille, Mathieu Peretti, Marie Eve Garcia, Roch Giorgi, Nathalie Ausias, Patrice Vanelle, Fabrice Barlesi, Marc Montana
Real-world efficacy and safety of pembrolizumab in patients with non-small cell lung cancer: a retrospective observational study. Tumori 107 (1) (2020)
Flora Laville, Marc Montana, Nicolas Roux, Pascal Rathelot, Roch Giorgi, Patrice Vanelle
Factors limiting adherence to antiepileptic treatment: A French online patient survey. Journal of clinical pharmacy and therapeutics 43 (1) (2017)
H Capelle, C Tummino, L Greillier, M Gouitaa, J Birnbaum, N Ausias, F Barlesi, Marc Montana
Retrospective study of hypersensitivity reactions to chemotherapeutic agents in a thoracic oncology service. Journal of clinical pharmacy and therapeutics 43 (3) (2017)
Camille Pierrisnard, Marjorie Baciuchka, Julien Mancini, Pascal Rathelot, Patrice Vanelle, Marc Montana
Body image and psychological distress in women with breast cancer: a French online survey on patients' perceptions and expectations. Breast cancer (Tokyo, Japan) 25 (3) (2017)